Definium Therapeutics
DFTX
#3073
Rank
NZ$9.30 B
Marketcap
NZ$69.28
Share price
-6.48%
Change (1 day)
360.10%
Change (1 year)

Earnings for Definium Therapeutics (DFTX)

Earnings in 2026 (TTM): -NZ$0.4 Billion

According to Definium Therapeutics's latest financial reports the company's current earnings are N/A. In 2025 the company made an earning of -NZ$0.31 Billion a decrease over its 2024 earnings that were of -NZ$0.18 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Definium Therapeutics from 2020 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -NZ$0.4 Billion31.64%
2025 -NZ$0.31 Billion67.59%
2024 -NZ$0.18 Billion13.68%
2023 -NZ$0.16 Billion41.1%
2022 -NZ$0.12 Billion-30.4%
2021 -NZ$0.17 Billion215.25%
2020 -NZ$51.12 Million